Dr Daniel Mahony
Mahony will continue as the UK government’s Life Sciences Investment Envoy
Read More
Tag: UK government
NIHR and TJBCM announce new funding initiative for novel brain tumour research
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
Read More
New report urges UK policymakers to take urgent action on declining child health
The report includes five recommendations for the government to address these issues
Read More
BHF data reveals early heart disease deaths rise to highest level
In 2022, over 39,000 people in England died prematurely of cardiovascular conditions
Read More
Secretary of state sets out priorities for UK health and social care systems
The commitments will make health systems faster, simpler and fairer for patients
Read More
Thousands of men to participate in UK trial for prostate cancer
Prostate cancer is responsible for 12,000 deaths every year in the UK
Read More
UK government to open 160 community diagnostic centres a year early
All CDCs will be open by March 2024 to speed up lifesaving checks and tests
Read More
UK government launches pathway for innovative technologies
IDAP aims to address unmet clinical needs for patients and healthcare professionals
Read More
Parkinson’s UK calls on government to mark World Patient Safety Day
The report outlines ways the government can help patients with Parkinson’s disease
Read More
UK government invests £200m to boost NHS resilience this winter
The funding will reduce waiting lists and ease the demand on the NHS during Winter
Read More
Multi-million-pound funding for genomics research
Vital financing will help boost diagnosis, treatment and prospects of patient groups
Read More
Parsortix system identifies key drug targets in cancer metastasis
Study demonstrates ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
